JP2007532117A - αアミラーゼ変異体 - Google Patents
αアミラーゼ変異体 Download PDFInfo
- Publication number
- JP2007532117A JP2007532117A JP2007507549A JP2007507549A JP2007532117A JP 2007532117 A JP2007532117 A JP 2007532117A JP 2007507549 A JP2007507549 A JP 2007507549A JP 2007507549 A JP2007507549 A JP 2007507549A JP 2007532117 A JP2007532117 A JP 2007532117A
- Authority
- JP
- Japan
- Prior art keywords
- amylase
- amino acid
- seq
- acid sequence
- starch
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 108090000637 alpha-Amylases Proteins 0.000 title claims abstract description 246
- 102000004139 alpha-Amylases Human genes 0.000 title claims abstract description 242
- 229940024171 alpha-amylase Drugs 0.000 title claims abstract description 218
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract description 67
- 238000000034 method Methods 0.000 claims abstract description 61
- 239000002243 precursor Substances 0.000 claims abstract description 43
- 241000193385 Geobacillus stearothermophilus Species 0.000 claims abstract description 34
- 230000000694 effects Effects 0.000 claims abstract description 20
- 238000012217 deletion Methods 0.000 claims abstract description 19
- 230000037430 deletion Effects 0.000 claims abstract description 19
- 229920002472 Starch Polymers 0.000 claims description 85
- 235000019698 starch Nutrition 0.000 claims description 85
- 239000008107 starch Substances 0.000 claims description 85
- 239000002002 slurry Substances 0.000 claims description 57
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 35
- 241000194108 Bacillus licheniformis Species 0.000 claims description 32
- 102000004190 Enzymes Human genes 0.000 claims description 29
- 108090000790 Enzymes Proteins 0.000 claims description 29
- 229940088598 enzyme Drugs 0.000 claims description 29
- 239000013604 expression vector Substances 0.000 claims description 18
- 230000001965 increasing effect Effects 0.000 claims description 17
- 239000000203 mixture Substances 0.000 claims description 17
- 244000063299 Bacillus subtilis Species 0.000 claims description 12
- 235000014469 Bacillus subtilis Nutrition 0.000 claims description 12
- 239000003599 detergent Substances 0.000 claims description 12
- 239000007788 liquid Substances 0.000 claims description 7
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 238000012258 culturing Methods 0.000 claims description 2
- 230000003625 amylolytic effect Effects 0.000 claims 1
- 230000008569 process Effects 0.000 abstract description 21
- 102000013142 Amylases Human genes 0.000 description 50
- 108010065511 Amylases Proteins 0.000 description 50
- 235000019418 amylase Nutrition 0.000 description 49
- 108090000623 proteins and genes Proteins 0.000 description 49
- 239000004382 Amylase Substances 0.000 description 42
- 210000004027 cell Anatomy 0.000 description 39
- 235000001014 amino acid Nutrition 0.000 description 32
- 150000001413 amino acids Chemical class 0.000 description 30
- 239000013612 plasmid Substances 0.000 description 29
- 108091028043 Nucleic acid sequence Proteins 0.000 description 27
- 235000018102 proteins Nutrition 0.000 description 26
- 102000004169 proteins and genes Human genes 0.000 description 26
- 239000013598 vector Substances 0.000 description 26
- 239000000243 solution Substances 0.000 description 25
- 150000007523 nucleic acids Chemical class 0.000 description 24
- 108020004414 DNA Proteins 0.000 description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 22
- 102000039446 nucleic acids Human genes 0.000 description 19
- 108020004707 nucleic acids Proteins 0.000 description 19
- 108010076504 Protein Sorting Signals Proteins 0.000 description 18
- 229930193140 Neomycin Natural products 0.000 description 12
- 229960004927 neomycin Drugs 0.000 description 12
- 229960005091 chloramphenicol Drugs 0.000 description 11
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 11
- 239000000758 substrate Substances 0.000 description 11
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 10
- 125000000539 amino acid group Chemical group 0.000 description 10
- 239000012153 distilled water Substances 0.000 description 10
- 108091033319 polynucleotide Proteins 0.000 description 10
- 102000040430 polynucleotide Human genes 0.000 description 10
- 239000002157 polynucleotide Substances 0.000 description 10
- 238000003556 assay Methods 0.000 description 9
- 230000007062 hydrolysis Effects 0.000 description 9
- 238000006460 hydrolysis reaction Methods 0.000 description 9
- 108090000765 processed proteins & peptides Proteins 0.000 description 9
- 239000000523 sample Substances 0.000 description 9
- 238000013518 transcription Methods 0.000 description 9
- 230000035897 transcription Effects 0.000 description 9
- 108010029675 Bacillus licheniformis alpha-amylase Proteins 0.000 description 8
- 230000004927 fusion Effects 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 7
- 108091005804 Peptidases Proteins 0.000 description 7
- 229940025131 amylases Drugs 0.000 description 7
- 239000012634 fragment Substances 0.000 description 7
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 7
- 238000012545 processing Methods 0.000 description 7
- 241000588724 Escherichia coli Species 0.000 description 6
- 241000282326 Felis catus Species 0.000 description 6
- 239000004365 Protease Substances 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 6
- 230000008901 benefit Effects 0.000 description 6
- 239000008187 granular material Substances 0.000 description 6
- 229920001184 polypeptide Polymers 0.000 description 6
- 102000004196 processed proteins & peptides Human genes 0.000 description 6
- 230000010076 replication Effects 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 5
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 5
- 230000003321 amplification Effects 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 210000000349 chromosome Anatomy 0.000 description 5
- 108020001507 fusion proteins Proteins 0.000 description 5
- 102000037865 fusion proteins Human genes 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 229910052740 iodine Inorganic materials 0.000 description 5
- 239000011630 iodine Substances 0.000 description 5
- 238000003199 nucleic acid amplification method Methods 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- 230000001131 transforming effect Effects 0.000 description 5
- 241000193744 Bacillus amyloliquefaciens Species 0.000 description 4
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 4
- 229920002245 Dextrose equivalent Polymers 0.000 description 4
- 108091005461 Nucleic proteins Proteins 0.000 description 4
- 102100026367 Pancreatic alpha-amylase Human genes 0.000 description 4
- 108010006785 Taq Polymerase Proteins 0.000 description 4
- 230000027455 binding Effects 0.000 description 4
- 229910001424 calcium ion Inorganic materials 0.000 description 4
- 230000002759 chromosomal effect Effects 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 101000775727 Bacillus amyloliquefaciens Alpha-amylase Proteins 0.000 description 3
- 238000001712 DNA sequencing Methods 0.000 description 3
- 229920001353 Dextrin Polymers 0.000 description 3
- 239000004375 Dextrin Substances 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 241000206602 Eukaryota Species 0.000 description 3
- 101000796304 Geobacillus stearothermophilus Alpha-amylase Proteins 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 230000003197 catalytic effect Effects 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 235000019425 dextrin Nutrition 0.000 description 3
- 238000009837 dry grinding Methods 0.000 description 3
- 125000001475 halogen functional group Chemical group 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 3
- 108020004999 messenger RNA Proteins 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- -1 modifies the cell Chemical class 0.000 description 3
- 239000002773 nucleotide Substances 0.000 description 3
- 125000003729 nucleotide group Chemical group 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
- 230000000750 progressive effect Effects 0.000 description 3
- 210000001938 protoplast Anatomy 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 238000010186 staining Methods 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 2
- 241000193422 Bacillus lentus Species 0.000 description 2
- 229920002261 Corn starch Polymers 0.000 description 2
- 102000012410 DNA Ligases Human genes 0.000 description 2
- 108010061982 DNA Ligases Proteins 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- 241000626621 Geobacillus Species 0.000 description 2
- 229920001503 Glucan Polymers 0.000 description 2
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 2
- 102100022624 Glucoamylase Human genes 0.000 description 2
- 102000005744 Glycoside Hydrolases Human genes 0.000 description 2
- 108010031186 Glycoside Hydrolases Proteins 0.000 description 2
- 101001056473 Homo sapiens Keratin, type II cytoskeletal 5 Proteins 0.000 description 2
- 102000004882 Lipase Human genes 0.000 description 2
- 108090001060 Lipase Proteins 0.000 description 2
- 239000004367 Lipase Substances 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- 102000035195 Peptidases Human genes 0.000 description 2
- 108020004511 Recombinant DNA Proteins 0.000 description 2
- 101100287028 Solanum lycopersicum ARPI gene Proteins 0.000 description 2
- 101100228946 Streptomyces fradiae neoB gene Proteins 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 238000005804 alkylation reaction Methods 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 2
- 239000000920 calcium hydroxide Substances 0.000 description 2
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 239000013068 control sample Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 239000008120 corn starch Substances 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 230000002538 fungal effect Effects 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
- 230000002779 inactivation Effects 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 235000019421 lipase Nutrition 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 125000000636 p-nitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)[N+]([O-])=O 0.000 description 2
- 229910052697 platinum Inorganic materials 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000017854 proteolysis Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 238000002864 sequence alignment Methods 0.000 description 2
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 2
- 235000019345 sodium thiosulphate Nutrition 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000013519 translation Methods 0.000 description 2
- 101150082952 ACTA1 gene Proteins 0.000 description 1
- 101710146708 Acid alpha-amylase Proteins 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 102100033770 Alpha-amylase 1C Human genes 0.000 description 1
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 1
- 229910000013 Ammonium bicarbonate Inorganic materials 0.000 description 1
- 229920000856 Amylose Polymers 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- 241000228245 Aspergillus niger Species 0.000 description 1
- 240000006439 Aspergillus oryzae Species 0.000 description 1
- 235000002247 Aspergillus oryzae Nutrition 0.000 description 1
- 241001328122 Bacillus clausii Species 0.000 description 1
- 241000193749 Bacillus coagulans Species 0.000 description 1
- 241000194103 Bacillus pumilus Species 0.000 description 1
- 108010006654 Bleomycin Proteins 0.000 description 1
- 241000201308 Boschniakia Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 241000193764 Brevibacillus brevis Species 0.000 description 1
- 101800001415 Bri23 peptide Proteins 0.000 description 1
- 101800000655 C-terminal peptide Proteins 0.000 description 1
- 102400000107 C-terminal peptide Human genes 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 101710140962 Capsid scaffolding protein Proteins 0.000 description 1
- 108010059892 Cellulase Proteins 0.000 description 1
- 102000005575 Cellulases Human genes 0.000 description 1
- 108010084185 Cellulases Proteins 0.000 description 1
- 108090000317 Chymotrypsin Proteins 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 125000002353 D-glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
- 108010083608 Durazym Proteins 0.000 description 1
- 108700034637 EC 3.2.-.- Proteins 0.000 description 1
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 108050001049 Extracellular proteins Proteins 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 101000779870 Homo sapiens Alpha-amylase 1B Proteins 0.000 description 1
- 101000779869 Homo sapiens Alpha-amylase 1C Proteins 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 102100025756 Keratin, type II cytoskeletal 5 Human genes 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 108010029785 Pancreatic alpha-Amylases Proteins 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 241000635201 Pumilus Species 0.000 description 1
- 230000004570 RNA-binding Effects 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000187747 Streptomyces Species 0.000 description 1
- 108700005078 Synthetic Genes Proteins 0.000 description 1
- 241000499912 Trichoderma reesei Species 0.000 description 1
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 125000003295 alanine group Chemical group N[C@@H](C)C(=O)* 0.000 description 1
- 235000012538 ammonium bicarbonate Nutrition 0.000 description 1
- 239000001099 ammonium carbonate Substances 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 101150009206 aprE gene Proteins 0.000 description 1
- 239000012131 assay buffer Substances 0.000 description 1
- 229940054340 bacillus coagulans Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- 229960001561 bleomycin Drugs 0.000 description 1
- OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 101150052795 cbh-1 gene Proteins 0.000 description 1
- 230000010307 cell transformation Effects 0.000 description 1
- 229940106157 cellulase Drugs 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229960002376 chymotrypsin Drugs 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 238000009990 desizing Methods 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 239000012470 diluted sample Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000004851 dishwashing Methods 0.000 description 1
- 238000011143 downstream manufacturing Methods 0.000 description 1
- 238000003366 endpoint assay Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 210000005254 filamentous fungi cell Anatomy 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000005188 flotation Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 244000144980 herd Species 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- PGLTVOMIXTUURA-UHFFFAOYSA-N iodoacetamide Chemical compound NC(=O)CI PGLTVOMIXTUURA-UHFFFAOYSA-N 0.000 description 1
- 238000000534 ion trap mass spectrometry Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000006317 isomerization reaction Methods 0.000 description 1
- 239000000231 karaya gum Substances 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000009988 metabolic benefit Effects 0.000 description 1
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002250 progressing effect Effects 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000007363 regulatory process Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000013605 shuttle vector Substances 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 230000005026 transcription initiation Effects 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2405—Glucanases
- C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
- C12N9/2411—Amylases
- C12N9/2414—Alpha-amylase (3.2.1.1.)
- C12N9/2417—Alpha-amylase (3.2.1.1.) from microbiological source
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/38—Products with no well-defined composition, e.g. natural products
- C11D3/386—Preparations containing enzymes, e.g. protease or amylase
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/38—Products with no well-defined composition, e.g. natural products
- C11D3/386—Preparations containing enzymes, e.g. protease or amylase
- C11D3/38618—Protease or amylase in liquid compositions only
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Detergent Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US56112404P | 2004-04-08 | 2004-04-08 | |
| PCT/US2005/012074 WO2005111203A2 (en) | 2004-04-08 | 2005-04-08 | MUTANT α ΑMYLASES |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007532117A true JP2007532117A (ja) | 2007-11-15 |
| JP2007532117A5 JP2007532117A5 (enExample) | 2008-05-22 |
Family
ID=35394736
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007507549A Ceased JP2007532117A (ja) | 2004-04-08 | 2005-04-08 | αアミラーゼ変異体 |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US20060014265A1 (enExample) |
| EP (1) | EP1733032A2 (enExample) |
| JP (1) | JP2007532117A (enExample) |
| CN (1) | CN1938422A (enExample) |
| BR (1) | BRPI0509671A (enExample) |
| CA (1) | CA2562171A1 (enExample) |
| WO (1) | WO2005111203A2 (enExample) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2011510665A (ja) * | 2008-02-04 | 2011-04-07 | ダニスコ・ユーエス・インク | バチルス・ステアロテルモフィルスアルファ・アミラーゼの変異種とその用途 |
| JP2011522536A (ja) * | 2008-06-06 | 2011-08-04 | ダニスコ・ユーエス・インク | 改善された性質を有するゲオバチルスステアロセレモフィリス（Ｇｅｏｂａｃｉｌｌｕｓｓｔｅａｒｏｔｈｅｒｍｏｐｈｉｌｕｓ）アルファアミラーゼ（ＡｍｙＳ）変異体 |
| JP2011525350A (ja) * | 2008-06-06 | 2011-09-22 | ダニスコ・ユーエス・インク | バシラス・スブチリス由来のアルファ−アミラーゼ変異体とその使用方法 |
| JP2012522514A (ja) * | 2009-04-01 | 2012-09-27 | ダニスコ・ユーエス・インク | 変化した特性を有するα−アミラーゼ変異体を含む組成物及び方法 |
Families Citing this family (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ528260A (en) | 2001-05-18 | 2005-09-30 | Danisco | Method of improving dough and bread quality with the addition of an enzyme that hydrolyses a glycolipid and a phospholipid and incapable of hydrolysing a triglyceride or monoglyceride |
| MX2007000626A (es) | 2004-07-16 | 2007-03-07 | Danisco | Enzima lipolitica; usos de la misma en la industria alimenticia. |
| ATE443760T1 (de) | 2006-05-31 | 2009-10-15 | Novozymes As | Chloramphenicolresistenz-selektion bei bacillus licheniformis |
| US7968318B2 (en) * | 2006-06-06 | 2011-06-28 | Genencor International, Inc. | Process for conversion of granular starch to ethanol |
| CA2657272C (en) * | 2006-07-13 | 2014-10-28 | Dsm Ip Assets B.V. | Use of bacterial amylases in feed for bovine animals |
| KR20090101193A (ko) * | 2006-12-21 | 2009-09-24 | 다니스코 유에스 인크. | 바실러스 종 １９５ 의 알파-아밀라아제 폴리펩티드에 대한 조성물 및 용도 |
| CN102559627B (zh) * | 2007-01-25 | 2014-09-10 | 杜邦营养生物科学有限公司 | 由地衣芽孢杆菌转化细胞制备脂酰基转移酶 |
| CN101652474B (zh) | 2007-01-25 | 2012-06-27 | 丹尼斯科有限公司 | 由地衣芽孢杆菌转化细胞制备脂酰基转移酶 |
| US20080220498A1 (en) * | 2007-03-06 | 2008-09-11 | Cervin Marguerite A | Variant Buttiauxella sp. phytases having altered properties |
| CA2677643C (en) * | 2007-02-07 | 2016-06-07 | Danisco Us Inc., Genencor Division | Starch hydrolysis using phytase with an alpha amylase |
| EP2137317A1 (en) | 2007-03-14 | 2009-12-30 | Danisco US, INC., Genencor Division | Production of ethanol from barley and ddgs containing reduced beta-glucan and phytic acid |
| WO2008118377A2 (en) | 2007-03-23 | 2008-10-02 | Danisco Us, Inc., Genencor Division | Enhanced amylase production by n-terminal addition to mature amylase protein |
| CN101848985B (zh) | 2007-11-05 | 2014-12-03 | 丹尼斯科美国公司 | 具有改变性质的杆菌物种TS-23的α-淀粉酶变体 |
| US8206966B2 (en) * | 2007-11-05 | 2012-06-26 | Danisco Us Inc. | Alpha-amylase variants with altered properties |
| WO2009067654A1 (en) * | 2007-11-21 | 2009-05-28 | Edda Technology, Inc. | Method and system for interactive percutaneous pre-operation surgical planning |
| MX2010007014A (es) | 2007-12-21 | 2010-09-30 | Danisco | Procedimiento para refinacion de aceite comestible utilizando una lipido aciltransferasa. |
| BRPI0908768A2 (pt) | 2008-02-04 | 2015-07-28 | Danisco Us Inc | Variantes de olfa-amilase de ts23 com propriedades alteradas |
| WO2009134670A2 (en) * | 2008-04-30 | 2009-11-05 | Danisco Us Inc., Genencor Division | New chimeric alpha-amylase variants |
| BRPI0915531A2 (pt) | 2008-06-06 | 2017-08-29 | Danisco Us Inc | Composição de enzima de sacarificação e método de sacarificação da mesma |
| EP2698434A1 (en) * | 2008-06-06 | 2014-02-19 | Danisco US Inc. | Uses of an alpha-amylase from Bacillus subtilis |
| BRPI0915681A2 (pt) | 2008-06-06 | 2015-08-04 | Danisco Us Inc | Composições e métodos compreendendo proteases microbianas variantes |
| MX2011003178A (es) | 2008-09-25 | 2011-04-21 | Danisco Inc | Mezclas de alfa-amilasa y metodos para usar esas mezclas. |
| BRPI1009263A2 (pt) | 2009-03-10 | 2015-10-06 | Danisco Us Inc | alfa-amilases relacionadas com cepa de bacillus megaterium dsm90 e métodos de uso das mesmas. |
| EP2417254B1 (en) | 2009-04-08 | 2014-05-21 | Danisco US Inc. | Halomonas strain wdg195-related alpha-amylases, and methods of use, thereof |
| US20110039307A1 (en) * | 2009-05-12 | 2011-02-17 | Henderson Jodi M | Ethanol yields in fermentation from an improved liquefaction process |
| US8545907B2 (en) | 2009-08-07 | 2013-10-01 | Danisco Us Inc. | Alpha-amylase blend for starch processing and method of use thereof |
| CA2778471A1 (en) | 2009-10-23 | 2011-04-28 | Danisco Us Inc. | Methods for reducing blue saccharide |
| GB0920089D0 (en) | 2009-11-17 | 2009-12-30 | Danisco | Method |
| US20120309038A1 (en) | 2010-02-22 | 2012-12-06 | Syngenta Participations Ag | Methods for distinguishing and identifying plant varieties |
| JP2014512828A (ja) | 2011-04-29 | 2014-05-29 | ダニスコ・ユーエス・インク | 発酵によるエタノールの収率を高めるためのセルラーゼ及びグルコアミラーゼの使用 |
| WO2013192598A1 (en) * | 2012-06-21 | 2013-12-27 | Excelsius Surgical, L.L.C. | Surgical robot platform |
| WO2014092960A1 (en) | 2012-12-11 | 2014-06-19 | Danisco Us Inc. | Trichoderma reesei host cells expressing a glucoamylase from aspergillus fumigatus and methods of use thereof |
| WO2015057517A1 (en) | 2013-10-17 | 2015-04-23 | Danisco Us Inc. | Use of hemicellulases to improve ethanol production |
| EP3157446B1 (en) * | 2014-06-19 | 2018-08-15 | KB Medical SA | Systems for performing minimally invasive surgery |
| US20180030456A1 (en) * | 2015-02-19 | 2018-02-01 | Danisco Us Inc. | Enhanced protein expression |
| WO2016201040A1 (en) | 2015-06-09 | 2016-12-15 | Danisco Us Inc. | Water-triggered enzyme suspension |
| JP7025325B2 (ja) | 2015-10-30 | 2022-02-24 | ダニスコ・ユーエス・インク | タンパク質発現の増強およびその方法 |
| AU2017222025A1 (en) * | 2016-02-26 | 2018-10-11 | Nanjing Bestzyme Bio-Engineering Co., Ltd. | Alpha amylase variant and use thereof |
| US20190367932A1 (en) | 2017-01-23 | 2019-12-05 | Danisco Us Inc. | Methods and compositions for obtaining natural comptence in bacillus host cells |
| WO2019040412A1 (en) | 2017-08-23 | 2019-02-28 | Danisco Us Inc | METHODS AND COMPOSITIONS FOR EFFICIENT GENETIC MODIFICATION OF BACILLUS LICHENIFORMIS STRAINS |
| CN108823186B (zh) * | 2018-07-03 | 2022-11-22 | 江西省科学院微生物研究所 | 一种玉米淀粉降解能力提高的嗜热酸性生淀粉α-淀粉酶突变体及其制备方法和应用 |
| CN110607305A (zh) * | 2019-08-30 | 2019-12-24 | 海南大学 | 斑马鱼α7乙酰胆碱受体重组载体及重组细胞 |
| CN116134536A (zh) | 2020-06-15 | 2023-05-16 | 布拉格分析股份有限公司 | 基于衍射的全局体外诊断系统 |
| PE20251535A1 (es) | 2022-05-14 | 2025-06-05 | Novozymes As | Composiciones y metodos para prevenir, tratar, suprimir y/o eliminar infecciones e infestaciones fitopatogenas |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH11503003A (ja) * | 1995-02-03 | 1999-03-23 | ノボ ノルディスク アクティーゼルスカブ | アミラーゼ変異体 |
| JP2000508914A (ja) * | 1996-04-30 | 2000-07-18 | ノボ ノルディスク アクティーゼルスカブ | α―アミラーゼ変異体 |
| WO2001064852A1 (en) * | 2000-03-03 | 2001-09-07 | Novozymes A/S | Polypeptides having alkaline alpha-amylase activity and nucleic acids encoding same |
| JP2001520006A (ja) * | 1997-10-13 | 2001-10-30 | ノボ ノルディスク アクティーゼルスカブ | α−アミラーゼ変異体 |
| JP2004500815A (ja) * | 1999-12-23 | 2004-01-15 | ジェネンコア インターナショナル インコーポレーテッド | 改良された機能特性を有するタンパク質を得る方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4760025A (en) * | 1984-05-29 | 1988-07-26 | Genencor, Inc. | Modified enzymes and methods for making same |
| US5264366A (en) * | 1984-05-29 | 1993-11-23 | Genencor, Inc. | Protease deficient bacillus |
| EP0208491B1 (en) * | 1985-07-03 | 1993-08-25 | Genencor International, Inc. | Hybrid polypeptides and process for their preparation |
| US6093562A (en) * | 1996-02-05 | 2000-07-25 | Novo Nordisk A/S | Amylase variants |
| US6361989B1 (en) * | 1997-10-13 | 2002-03-26 | Novozymes A/S | α-amylase and α-amylase variants |
| US6309871B1 (en) * | 1999-03-31 | 2001-10-30 | Novozymes A/S | Polypeptides having alkaline α-amylase activity |
| ATE400648T1 (de) * | 2000-08-11 | 2008-07-15 | Genencor Int | Transformation von bacillus, transformanten und mutanten-bibliotheken |
-
2005
- 2005-04-08 US US11/102,188 patent/US20060014265A1/en not_active Abandoned
- 2005-04-08 BR BRPI0509671-5A patent/BRPI0509671A/pt not_active Application Discontinuation
- 2005-04-08 CN CNA2005800099139A patent/CN1938422A/zh active Pending
- 2005-04-08 CA CA002562171A patent/CA2562171A1/en not_active Abandoned
- 2005-04-08 JP JP2007507549A patent/JP2007532117A/ja not_active Ceased
- 2005-04-08 EP EP05777632A patent/EP1733032A2/en not_active Withdrawn
- 2005-04-08 WO PCT/US2005/012074 patent/WO2005111203A2/en not_active Ceased
-
2007
- 2007-04-06 US US11/784,405 patent/US20080160573A1/en not_active Abandoned
-
2009
- 2009-03-09 US US12/400,722 patent/US20100261232A1/en not_active Abandoned
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH11503003A (ja) * | 1995-02-03 | 1999-03-23 | ノボ ノルディスク アクティーゼルスカブ | アミラーゼ変異体 |
| JP2000508914A (ja) * | 1996-04-30 | 2000-07-18 | ノボ ノルディスク アクティーゼルスカブ | α―アミラーゼ変異体 |
| JP2001520006A (ja) * | 1997-10-13 | 2001-10-30 | ノボ ノルディスク アクティーゼルスカブ | α−アミラーゼ変異体 |
| JP2004500815A (ja) * | 1999-12-23 | 2004-01-15 | ジェネンコア インターナショナル インコーポレーテッド | 改良された機能特性を有するタンパク質を得る方法 |
| WO2001064852A1 (en) * | 2000-03-03 | 2001-09-07 | Novozymes A/S | Polypeptides having alkaline alpha-amylase activity and nucleic acids encoding same |
Non-Patent Citations (2)
| Title |
|---|
| JPN6010068981, Ｊ Ｂｉｏｌ Ｃｈｅｍ．， ２６４［３２］ （１９８９） ｐ．１８９３３−８． * |
| JPN6010068982, ＢＢＲＣ．， ２４８ （１９９８） ｐ．３７２−３７７ * |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2011510665A (ja) * | 2008-02-04 | 2011-04-07 | ダニスコ・ユーエス・インク | バチルス・ステアロテルモフィルスアルファ・アミラーゼの変異種とその用途 |
| JP2011522536A (ja) * | 2008-06-06 | 2011-08-04 | ダニスコ・ユーエス・インク | 改善された性質を有するゲオバチルスステアロセレモフィリス（Ｇｅｏｂａｃｉｌｌｕｓｓｔｅａｒｏｔｈｅｒｍｏｐｈｉｌｕｓ）アルファアミラーゼ（ＡｍｙＳ）変異体 |
| JP2011525350A (ja) * | 2008-06-06 | 2011-09-22 | ダニスコ・ユーエス・インク | バシラス・スブチリス由来のアルファ−アミラーゼ変異体とその使用方法 |
| JP2012522514A (ja) * | 2009-04-01 | 2012-09-27 | ダニスコ・ユーエス・インク | 変化した特性を有するα−アミラーゼ変異体を含む組成物及び方法 |
| JP2012522875A (ja) * | 2009-04-01 | 2012-09-27 | ダニスコ・ユーエス・インク | アルファ‐アミラーゼ及びプロテアーゼを含む洗浄組成物及び方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2005111203A3 (en) | 2006-03-30 |
| US20080160573A1 (en) | 2008-07-03 |
| WO2005111203A2 (en) | 2005-11-24 |
| CA2562171A1 (en) | 2005-11-24 |
| US20060014265A1 (en) | 2006-01-19 |
| EP1733032A2 (en) | 2006-12-20 |
| CN1938422A (zh) | 2007-03-28 |
| BRPI0509671A (pt) | 2007-10-30 |
| US20100261232A1 (en) | 2010-10-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007532117A (ja) | αアミラーゼ変異体 | |
| EP1038007B1 (en) | Mutant bacillus licheniformis alpha-amylase | |
| EP0832250B1 (en) | Mutant alpha-amylase | |
| EP0938570B1 (en) | Mutant alpha-amylase comprising modification at residues corresponding to a210, h405 and/or t412 in bacillus licheniformis | |
| EP1002098B1 (en) | Mutant alpha-amylase having introduced therein a disulfide bond | |
| KR100322793B1 (ko) | 산화안정성알파-아밀라아제 | |
| US5958739A (en) | Mutant α-amylase | |
| AU686007B2 (en) | An improved cleaning composition | |
| JP4253041B2 (ja) | 改良された安定性を有するタンパク質 | |
| DK2935575T3 (en) | ALPHA-amylase variants | |
| MXPA97009472A (en) | Alfa amilasa muta | |
| JPH11502562A (ja) | アミラーゼを含有する改善された洗濯洗剤組成物 | |
| EP2970929A1 (en) | Alpha-amylase combinatorial variants | |
| CN104066838A (zh) | 变体α-淀粉酶及其使用方法 | |
| WO2014099525A1 (en) | Paenibacillus curdlanolyticus amylase, and methods of use, thereof | |
| NZ524303A (en) | Alpha amylase enzymes with increased stability | |
| MXPA99003634A (en) | MUTANT&agr;-AMYLASE COMPRISING MODIFICATION AT RESIDUES CORRESPONDING TO A210, H405 AND/OR T412 IN BACILLUS LICHENIFORMIS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080401 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20080401 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20101130 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20110225 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20110304 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20110330 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20110406 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110531 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20111115 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120213 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20120501 |
|
| A045 | Written measure of dismissal of application [lapsed due to lack of payment] |
Free format text: JAPANESE INTERMEDIATE CODE: A045 Effective date: 20120925 |